Interventional Neuroradiology Market Report 2026

Interventional Neuroradiology Market Overview

• Interventional Neuroradiology market size has reached to $2.05 billion in 2025 • Expected to grow to $2.73 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Neurological Disorders Fuel Market Growth • Market Trend: Enhancing Procedural Accuracy With Head Immobilizers In Interventional Neuroradiology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interventional Neuroradiology Market?

Interventional neuroradiology (INR) refers to a specialized field of medicine that focuses on minimally invasive procedures to diagnose and treat various neurological conditions affecting the brain, spine, and blood vessels. It involves using advanced imaging techniques to guide the performance of treatments like catheter-based procedures, angioplasties, stent placements, and embolization. The main types of devices in interventional neuroradiology are microcatheters, neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, and micro guidewires. Microcatheters are thin, flexible tubes designed for navigating small and complex blood vessels in the brain and spine during interventional procedures. It is used for various disease types, including cerebral aneurysms, intracranial tumors, acute strokes, and others, catering to various end users, including hospitals, ambulatory surgical centers, and diagnostic centers.

What Is The Interventional Neuroradiology Market Growth Forecast?

The interventional neuroradiology market size is expected to see strong growth in the next few years. It will grow to $2.73 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rising global burden of neurological disorders, increasing adoption of flow diversion and embolization technologies, growing demand for faster stroke intervention, technological advancements in microcatheters and guidewires, expanding investments in neurointerventional research. Major trends in the forecast period include growing preference for minimally invasive neurovascular procedures, rising adoption of endovascular treatment for acute stroke, expansion of advanced neurovascular device portfolios, increasing focus on improved procedural precision and safety, growth in specialized interventional neuroradiology centers.

Global Interventional Neuroradiology Market Segmentation

1) By Device Type: Microcatheters, Neurovascular Embolization And Coiling Assist Devices, Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Accessories, Micro Guidewires 2) By Disease: Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Other Diseases 3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers Subsegments: 1) By Microcatheters: Single-Lumen Microcatheters, Dual-Lumen Microcatheters, High-Flow Microcatheters 2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices, Embolization Assist Devices 3) By Embolic Coils: Soft Coils, Stiff Coils, Detachable Coils 4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices, Non-Stent-Based Flow Diversion Devices 5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents, Gel-Based Liquid Embolic Agents, Onyx Liquid Embolic Agents 6) By Accessories: Guide Catheters, Sheath Introducers, Vascular Access Devices 7) By Micro Guidewires: Hydrophilic Micro Guidewires, Pushable Micro Guidewires, Coated Micro Guidewires

What Is The Driver Of The Interventional Neuroradiology Market?

The growing prevalence of neurological disorders is expected to propel the growth of the interventional neuroradiology market going forward. Neurological disorders are medical conditions affecting the brain, spinal cord, or peripheral nerves, impairing movement, sensation, cognition, or communication. The prevalence of neurological disorders is increasing due to the aging global population, which raises the risk of age-related conditions such as Alzheimer's, and improved diagnostic technologies that allow for earlier and more accurate detection of such disorders. Interventional neuroradiology is used for neurological disorders by employing minimally invasive, image-guided techniques to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For instance, in October 2023, according to the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, more than 40% of the global population were living with a neurological condition, and the overall neurological disease burden was projected to nearly double by 2050. Therefore, the growing prevalence of neurological disorders is driving the growth of the interventional neuroradiology industry.

Key Players In The Global Interventional Neuroradiology Market

Major companies operating in the interventional neuroradiology market are Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, Medico's Hirata Inc.

Global Interventional Neuroradiology Market Trends and Insights

Major companies operating in the interventional neuroradiology market are focusing on developing technologically advanced solutions, such as head immobilizers designed to enhance imaging quality and patient safety during interventional radiology and neuroradiology procedures. A head immobilizer is a medical device designed to temporarily render a patient's head and neck immovable, primarily to ensure safety and stability when there is a suspected head or spinal injury. For instance, in June 2023, Adept Medical, a New Zealand-based medical devices manufacturing company, launched a new head immobilizer, designed to enhance patient comfort and imaging quality during interventional radiology and neuroradiology procedures. This innovative device features vacuum suction technology for secure head fixation, a radiolucent design that minimizes interference with X-ray imaging, and compatibility with various imaging tables. Its quick setup process streamlines workflows, while its ability to accommodate different head shapes ensures patient comfort.

What Are Latest Mergers And Acquisitions In The Interventional Neuroradiology Market?

In January 2023, GE Healthcare Technologies Inc., a US-based healthcare company, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE Healthcare aims to enhance its interventional guidance offerings with CT-Navigation technology, improving procedural accuracy, reducing variability, and expanding capabilities in interventional radiology while scaling IMACTIS's solutions across medical fields. IMACTIS is a France-based medical technology company focusing on computed tomography for navigation systems.

Regional Outlook

North America was the largest region in the interventional neuroradiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Interventional Neuroradiology Market?

The interventional neuroradiology market consists of revenues earned by entities by providing services such as embolization procedures, balloon angioplasty, endovascular coiling, and mechanical thrombectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional neuroradiology market also includes sales of embolization agents, guidewires, microsurgical instruments, and neurovascular catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Interventional Neuroradiology Market Report 2026?

The interventional neuroradiology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neuroradiology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.